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Background: Stellera chamaejasme L, a traditional Chinese herb, has long been used for treatment of various
tumors in the Chinese population. In our previous study, we paid an attention to the cytotoxic and proapoptotic
effects of Stellera chamaejasme L extracts (ESC, ESC-1 and ESC-2, the latter two were isolated from ESC) on 4 various
tumor cells (NCI-H157, NCI-H460, BEL-7402 and SK-HEP-1) in vitro. ESCs showed significantly inhibitory effects on the
4 tumor cells. ESC-2 had the strongest inhibitory effect and the broadest sensitive cell spectrum. ESC-2 and ESC
acted in a similar way against tumor cells, which suggested anti-tumor active fraction of ESC might exist in ESC-2.
Here, we further observe the inhibitory and proapoptotic effects of Stellera chamaejasme L extracts in vivo.
Methods: In this study, we used hollow fiber tumor model to evaluate the inhibitory and proapoptotic effects of
Stellera chamaejasme L extracts. Apoptotic rates of the cancer cells retrieved from the hollow fibers were measured
with flow cytometric analysis, caspase 3, 8, 9 enzyme activities were detected by colorimetric assay, Fas, Fas-L,
TNF-R1 and TNF-α expression were determined with elisa assay and radioimmunoassay respectively.
Results: The results showed that ESC, ESC-2 all had inhibitory effects on 4 tumor cells. According to the effect
strength, dose and antitumor spectrum, the order of antitumor effects of ESCs was: ESC-2 > ESC > ESC-1. NCI-H460
cells were the most sensitive to ESCs. ESC, ESC-2 increased greatly the apoptotic rate and caspase 3, 8 enzyme
activities in NCI-H460. ESCs had no significant effects on expression of Fas, Fas-L protein, but TNF-α/TNFR1 protein
expression in NCI-H460 cells changed significantly after ESC and ESC-2 treatment.
Conclusion: ESC-2 had the similar antitumor effect to that of ESC in vivo and further confirmed that ESC-2 may be
the main antitumor active fraction of ESC, which was consistent with our previous results in vitro.
Keywords: Stellera chamaejasme L, Hollow fiber assay, Apoptosis, Caspase activity, Fas, TNF-αBackground
In vitro cytotoxicity experiment is the first step for screen-
ing or discovery of anti-tumor drug. It has the advantages
of reducing substantially the amount of test drugs, deter-
mining the tumor specificity of the test drugs, simple
experiment, low cost, etc. So, it is also easily adopted as
the approach for pharmacological researchers to tracing
active ingredients or fractions of most anti-tumor nature* Correspondence: zhuxx59@163.com
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reproduction in any medium, provided the orproducts, especially medicinal herbs. However, each herb
in body is subjected to process of transport and metabol-
ism, which makes the experimental results in vitro and
in vivo always inconsistent. In particular, distinctive action
characteristics of traditional Chinese herbs based on its in-
tegrity and interaction with the body determine the im-
portance and necessity of investigating the efficacy in vivo.
Therefore animal experiments must be conducted to ver-
ify the validity of the test samples, which is the critical step
for active ingredients or fractions screening of traditional
Chinese herbs. Xenograft is once the main the model for
anti-tumor drug screening. But this kind of model is diffi-
cult to be as the large-scale screening method because itThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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test samples, consuming large amounts of time and man-
power. Hollow fiber assay (HFA) is a high-throughput
in vivo screening system built up by US National Cancer
Institute (NCI) in 1995 [1] and has become one of the
conventional anticancer drug screening method in NCI,
which make it become reality to screen antitumor agents
in large scale [2]. Because HFA can provide the real
in vivo environment,in accordance with the action charac-
teristics of natural products involving traditional Chinese
herbs, HFA has potential broad application prospects in
antitumor research field of traditional Chinese herbs and
other natural products [3]. Moreover, a large number of
research results showed that HFA was also an effective
method to quickly research pharmacodynamics (e.g., Per-
villeines B and C [4], Paclitaxel and Pacliex [5], C1311 and
SJG-13 [6], ASI-145 [7], YSL [8], TAS-102 [9]) and mech-
anism (e.g., PCNA and Rb [10], p16 [11], NF-kappa B
[12]) of antitumor drugs.
In our previous study, we paid attention to the cyto-
toxic and proapoptotic effects of Stellera chamaejasme L
(a traditional Chinese herb) extracts (ESC, ESC-1 and
ESC-2 were obtained with special techniques described
as Materials and Methods below) on 4 various tumor
cells (two lung cancer cell lines: NCI-H157 and NCI-
H460; two liver cancer cell lines: BEL-7402 and SK-
HEP-1) in vitro. The results showed ESC, ESC-1, ESC-2
all had inhibitory effects on the 4 tumor cells. On
72 hours, inhibition rates of 100, 200 μg/mL ESCs on
the 4 tumor cells were 64.82%-92.27%. ESC-2 had the
strongest inhibitory effect and the broadest sensitive cell
spectrum. GI50, TGI and LC50 of ESC-2 were similar to
those of ESC. These results suggested that antitumor ef-
fects of ESC-2 and ESC acted in a similar way, anti-tumor
active fractions of ESC may exist in ESC-2 [13]. ESC and
ESC-2 could induce the apoptosis by activating the key
proteins of tumor apoptosis pathway in NCI-H460 cells
[14,15]. Here, we further observe the inhibitory and proa-
poptotic effects of Stellera chamaejasme L extracts using
HFA to confirm the in vitro effects of ESCs.
Methods
Preparation of Stellera chamaejasme L extracts
Process of ESC (extract of Stellera chamaejasme L) was
given in another paper [14], ESC was mixed with re-
versed silica, filtered through a C18 column and eluted
with 70%, 100% methanol respectively and the final sam-
ples were ESC-1 and ESC-2. Part components of ESCs
were determined by 2695-996 Waters Alliance HPLC
and Finnigan TSQ mass spectrometer to control the
quality of ESCs (By Xiao HB, Dalian Institute of Chem-
ical Physics, Chinese Academy of Sciences). The primary
plant of Stellera chamaejasme L was identified by He XR
at Institute of Chinese Materia Medica, China Academyof Chinese Medical Sciences where all testing samples
were deposited.
Materials and reagents
RPMI-1640 medium, fetal bovine serum (FBS), penicillin-
streptomycin and trypsin- ethylenediaminetetraacetic acid
(EDTA)were purchased from Gibco (Grand Island, NY,
USA). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT), dimethyl sulfoxide (DMSO) and protam-
ine were provided by Sigma Chemical Co. (St. Louis, MO,
USA). 5-fluorouracil (5-FU) injection was from Shang Hai
Xu Dong Hai Pu Pharmaceutical Co. Ltd, Shanghai, China.
Acutase was purchased from EBioScience (San Diego, CA,
USA). Caspase-3,-8 colorimetric protease assay kits were
purchased from Chemicon International, Inc. (Temecula,
CA, USA). Fas, Fas-L, tumor necrosis factor receptor-1
(TNF-R1) ELISA kits were from R&D Systems (Minneapolis,
MN, USA). Tumor necrosis factor-α (TNF-α) radioimmuno-
assay kit was from the radioimmunoassay institute of
General Hospital of PLA, China. The biocompatible modi-
fied polyvinylidene difluoride (mPVDF) hollow fibers (Cell-
Maxs Implant Membranes) with a Mr 500 kDa cutoff and
1.0 mm inner diameter were purchased from Spectrum
Laboratories Inc. (Breda, The Netherlands). All the other
chemicals used, unless otherwise stated, were obtained
from Sigma Chemicals.
Animals and animal ethical statement
Six to eight weeks old male Nu/Nu Nude Mice (from
Beijing Vital River Laboratory Animal Technology Co. Ltd)
were raised and maintained under specific pathogen free
(SPF) sterile condition. All studies involving animals were
conducted according to the welfare and ethical guidelines
for experimental animal drafted by Beijing Experimental
Animal Management Office (Executed on January 1, 2006)
and approved by Committee for Control and Supervision
of Experiments on Animals of Institute of Chinese Materia
Medica, China Academy of Chinese Medical Sciences.
Cell culture
Two non-small-cell lung carcinoma cell lines of NCI-
H157, NCI-H460 were purchased from the Cell Culture
Center of the Chinese Academy of Medical Science. Two
liver cancer cell lines of BEL-7402, SK-HEP-1 were ob-
tained from Cell Bank, Shanghai Institutes for Biological
Sciences, Chinese Academy of Sciences. Cells were grown
in 1640 medium containing 10% (v/v) FBS and incubated
at 37°C in a 5% CO2 humidified atmosphere.
Preparation and in vivo implantation of the hollow fibers
The hollow fiber tumor models were made by referring
to the method of Hollingshead MG [1]. Hollow fibers
were flushed with 70% ethanol solution followed by dis-
tilled water for hydration, then autoclaved (121°C for
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tray at 4°C to wait for to be used. Cells were cultured in
accordance with the method described above. Cell density
was controlled at 70-90% confluence at the day of the im-
plantation. Cells were digested conventionally, adjusting
the cell concentration in the range of 1 × 106-10 × 106/ml.
Cell counts and activity identification were used trypan
blue exclusion method. Adding an appropriate amount of
1640 medium containing 20% FBS to adjust the cells to a
desired concentration, hollow fibers were removed from
the tray and placed on the work surface flushed with cold
fresh medium. Cells were injected into the fibers with a
syringe (18 gauge needle) and fibers were sealed every
2 cm with heat-sealer for 3-5 seconds. Fibers were cut
off in the middle of the heat seal segments. Fibers were
put into 6-well plates preloaded with medium to cul-
ture overnight. Every nude mouse was anesthetized
with sodium pentobarbital and the abdomen was in-
cised, inserting the hollow fibers into abdominal cavity.
After abdominal incision was sutured, a small incision
was made in the back neck and hollow fibers were
placed subcutaneously through the transplant casing.
Cytotoxic assessment of ESCs
45 male nude mice (body weight range was 18-20 g) were
made into hollow fiber tumor models according to the
method above. Every mouse was loaded with 4 tumor
cells: NCI-H157, NCI-H460, BEL-7402 and SK-HEP-1.
These mice were divided into nine groups according to
the weight: control (saline), solvent (10%DMSO), 20 mg/
kg 5-Fu, 4.5 mg/kg ESC, 3.0 mg/kg ESC, 25 mg/kg ESC-1,
16.75 mg/kg ESC-1, 1.5 mg/kg ESC-2, 1.0 mg/kg ESC-2.
The mice were treated on 4 day by intraperitoneal admin-
istration with ESCs (The doses of ESCs were based on the
results of their maximum tolerated dose (MTD) experi-
ments, the high dose = [MTD× 1.5]/4 and the low dose =
0.67 × the high dose [2]). The mice were sacrificed at day
8 and the fibers were retrieved from the mice. Excess host
tissue was removed and the fibers were transferred into
prewarmed medium and incubated for at least 1 h to be
waited for pharmacodynamic analysis. The MTT assay
was used to determine cytotoxicity of the cancer cells to
the ESCs after isolation of the fibers. The fibers were
placed into 2 ml of fresh, prewarmed 1640 medium in six-
well plates and allowed to equilibrate for 30 min at 37°C.
Prewarmed 1640 medium (1.5 ml) containing 1 mg MTT/
ml was added to each well. After a 4 h incubation at 37°C
in a 5% CO2 humidified atmosphere, the culture medium
was aspirated and 2 ml normal saline containing 2.5% pro-
tamine sulphate was added into each well. The fibers were
stored at 4°C for 24 h. Each fiber was transferred to 24-
well plates after being removed debris outside of the fi-
bers. The fibers were cut into half and dried at room
temperature (RT). 250 μl DMSO was added into each wellto dissolve formazan crystals for 4 h at RT on a rotating
platform while protected from the light. Aliquots of 150 μl
of extracted solution were transferred to individual wells
in 96-well plates and absorbance value was measured at
490 nm using a spectrophotometer (ELX800 type, BIO-
TEX Instruments, INC, Winooski, VT, USA). The inhib-
ition rate (IR) was calculated as follows.
Inhibition rate %ð Þ ¼ 1−ODtreatment−ODpre‐implantation
ODsolvent−ODpre‐implantation
Determination of apoptotic effects induced by ESCs
36 male nude mice (body weight range was 18-20 g), ac-
cording to the above method, were charged hollow fibers
with NCI-H460 lung cancer cells intraperitoneally and
subcutaneously. Mice were divided into control, 20 mg/
kg 5-Fu, 4.5 mg/kg ESC, 3.0 mg/kg ESC, 1.5 mg/kg
ESC-2, 1.0 mg/kg ESC-2. The administration method
was same as that mentioned above. On the collection
day, the fibers were removed from sacrificed mice and
transferred to 6-well plates added with 2 ml preheating
acutase to digest for 30 min. Then the cells were flush
out from fibers to be wait for detection of indexes re-
lated to apoptosis.
Measurement of apoptotic rate
The cancer cells were retrieved from the fibers and pre-
pared for flow cytometric analysis to measure apoptotic
rate. Briefly, the cells were washed with phosphate bal-
anced solution (PBS) and fixed with 70% ethanol for
30 min on ice. After centrifugation, the pellet was resus-
pended in 400 ml hypotonic propidium iodide (PI) solu-
tion (containing 0.5 mg/ml Ribonuclease, 50 mg/ml PI,
1 mg/ml sodium citrate, 1 ml/ml Triton X-100 in saline)
and incubated on ice in the dark for at least 15 min.
Then the cells were analysized by flow cytometer (Becton-
Dickinson, USA).
Detection of caspase activities
Caspase 3, 8, 9 activities were measured with caspase
assay kits. 1 × 106 cells were collected from fibers and
lysised with lysate on ice for 10 min and centrifuged at
20,000 g for 15 min. The supernatant was transferred to
a pre-cooled centrifuge tube and determined the activ-
ities of caspases immediately. Reaction system was set
according to kits and incubated at 37°C for 120 min. Ab-
sorbance value was measured at 405 nm when the reac-
tion system color obviously changed. If the color did not
change significantly, incubation time of reaction system
may be extended, even overnight incubation. Deference
of A405 absorbance between treatment and the control
was p-nitroaniline (pNA) absorbance of sample catalyzed
by caspases. Catalytic amount of pNA of can be calculated
Liu et al. BMC Complementary and Alternative Medicine 2014, 14:116 Page 4 of 8
http://www.biomedcentral.com/1472-6882/14/116through the pNA standard curve. Enzyme activity unit
was defined as the amount of caspase enzyme catalyzing
1 nmol pNA substrate when the substrate was saturation.
Each sample protein concentration was determined by
Bradford method to calculate the enzyme activity in unit
weight of protein of sample.
Expression of Fas, Fas-L, TNF-R1 with Elisa assay
Cells removed from fibers were collected after conven-
tional digestion and cleavage. The standard was diluted
according to the Elisa kit. 100 μl standard or each test
sample was added into wells of reaction plates and incu-
bated for 120 min at 37°C. Plates were washed with
washing liquid 5 times, and then first antibody working
solution of 100 μl was added and incubated for 60 min
at 37°C. Plates were washed another time. 100 μl Horse-
radish Peroxidase (HRP) working solution was added
and incubated for 30 min. Plates were washed again.
100 μl substrate working solution was added and reacted
in the dark for 15 min at 37°C, and then 100 μl of Stop
Solution was added. Absorbances of samples were mea-
sured at 450 nm in microplate reader within 30 min.
Expression of TNF-α with radioimmunoassay
Cells flushed from the hollow fibers were washed with PBS,
and then cells were lysised with ultrasonic cell crasher.
Using liquid competitive inhibition principle, the cell sam-
ples were determined with balance method. The samples or
standard and limited antisera or antigen together generated
competitive binding reaction. After the reaction, added
immune separating agent to isolating the antigen-antibody
complex, radioactivity of compound was determined and
the standard combination rate was calculated. Make the
standard curve and determine the sample concentration.
Statistical analysis
All results were expressed as mean ± SD. One way analysis
of variance (ANOVA) with multiple comparison tests was
used. P < 0.05 was considered as significant. Statistical
tests were performed using SPSS version 12.0.
Results
Comparisons of anti-tumor activities of ESCs based on
HFA
For the NCI-157 cells: In the SC (subcutaneous) fibers,
the IRs of 4.5,3.0 mg/kg ESC and 1.5 mg/kg ESC-2 were
43.05%, 77.15% and 43.13% respectively; In the IP (intra-
peritoneal) fibers, the IRs of 4.5 mg/kg ESC and 1.0 mg/
kg ESC-2 were 96.33% and 49.78% respectively. For the
NCI-H460 cells: In the SC fibers, the IRs of 4.5,3.0 mg/
kg ESC, 1.5,1.0 mg/kg ESC-2 and 16.75 mg/kg ESC-1
were 98.62%, 60.01%, 79.71%, 100.84% and 45.54% re-
spectively; In the IP fibers, the IRs of 4.5 mg/kg ESC and
1.5,1.0 mg/kg ESC-2 were 48.70% and 68.71%,108.34%respectively. For the Bel-7402 cells, In the SC fibers,
the IRs of 1.0 mg/kg ESC-2 and 25 mg/kg ESC-1 were
43.91% and 55.03% respectively; In the IP fibers, the IR
of 4.5 mg/kg ESC was 43.38%. For the SK-HEP-1 cells:
In the SC fibers, the IR of 4.5 mg/kg ESC was 40.24%;
In the IP fibers, the IRs of 4.5, 3.0 mg/kg ESC, 1.5,1.0 mg/
kg ESC-2 were 46.78%, 52% and 44.42%, 47.33%. The re-
sults showed that ESC and ESC-2 have obvious toxicity to
4 tumor cells in hollow fibers loaded in nude mice (see
Figure 1).Apoptosis induced by ESCs in NCI-H460 cells from the
implanted hollow fibers
Retrieval of the cells from the implanted fibers enabled
to evaluate apoptosis induction. The cells retrieved from
the fibers in control animals contained on average 7.40 ±
2.78 apoptotic cells. Otherwise, the cells retrieved from
the fibers in 4.5, 3.0 mg/kg ESC and 1.5,1.0 mg/kg ESC-2
treatment groups contained on average 20.86 ± 2.39,
19.09 ± 3.60, 23.35 ± 4.45, 18.76 ± 6.58 apoptotic cells re-
spectively, about 2.54 to 3.16 fold increase to that of con-
trol group (see Figure 2).Influence of ESCs on caspase 3, 8, 9 activities in NCI-H460
cells from the implanted hollow fibers
4.5, 3.0 mg/kg ESC and 1.5 mg/kgESC-2 can significantly
improve caspase 3 enzyme activity of NCI-H460 cells and
increase 1.76,1.47 and 1.41 folds (41.17 ± 6.74, 34.49 ±
2.40,32.80 ± 1.59) respectively compared to that of con-
trol group (23.32 ± 2.26); 4.5 mg/kg ESC and 1.5 mg/kg
ESC-2 can also significantly improve caspase 8 enzyme
activity of NCI-H460 cells and increase 1.49 and 1.47 folds
(19.98 ± 4.19,19.69 ± 2.54,) compared to that of control
group (13.40 ± 4.17); but ESCs did not increase the caspase
9 enzyme activity of NCI-H460 cells (see Figure 3).Influence of ESCs on expression of Fas and Fas-L in
NCI-H460 cells from the implanted hollow fibers
Compared with the control group, Fas and Fas-L expres-
sion of NCI-H460 cells in all ESCs groups has no signi-
ficant increase (see Figure 4).Influence of ESCs on expression of TNF-α and TNFR1 in
NCI-H460 cells from the implanted hollow fibers
3.0 mg/kg ESC(1.29 ± 0.03) significantly improved ex-
pression of TNF-α in NCI-H460 cells, whereas 1.5,
1.0 mg/kg ESC-2 (0.24 ± 0.09,0.33 ± 0.13) decreased sig-
nificantly in NCI-H460 cell compared with the control
group (0.78 ± 0.36); 1.0 mg/kg ESC-2 (39.10 ± 10.15)
increased significantly TNFR1 expression in NCI-H460
cell compared with the control group(20.07 ± 3.02) (see
Figure 5).
Figure 1 Antitumor activities of ESCs on 4 tumor cell lines (NCI-H460, NCI-H157, SK-HEP-1 and BEL-7402) based on hollow fiber assay.
SC: subcutaneous fibers, IP: intraperitoneal fibers.
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In this study, we used hollow fiber assay (bearing NCI-
H157, NCI-H460, BEL-7402, SK-HEP-1 4 tumor cell
lines, subcutaneously and intraperitoneally implanted
sites for each cell line for every animal)to evaluate the
anti-tumor pharmacological effects of Stellera chamae-
jasme L Extracts in vivo and traced the main fragments
of Stellera chamaejasme L. Of all the ESCs treatment
mice, the average body weight losses were all <20% with
no drug-related deaths, suggesting that all the experi-
ment mice could tolerate ESCs during the experimental
process.
It was considered positive that in vivo inhibition rate
was more than 40% according to evaluation standard of
in vivo antitumor nature product crude extract [16]. The
hollow fiber assay results showed that ESC, ESC-2 had
obvious in vivo cytotoxic effect and both produced >40%
growth inhibition on four tumor cell lines, ESC-1 only
one dose had certain inhibition on NCI-H460 and BEL-
7402 cells. Especially, the cell killing effect (a reduction
in cell mass below the input mass and inhibition rateFigure 2 Apoptosis induced by ESCs in NCI-H460 cells from the
implanted hollow fibers in vivo. The data were expressed as
mean ± SD (n = 12 per group). *p < 0.05, significant versus
control group.was more than 100%) was observed in NCI-H460 cell
line in mice of ESC-2 group. Therefore, the order of an-
titumor effects of ESCs was comprehensively evaluated
according to the effect strength (ESC-2 had cell killing
effect), effect dose (administration dose of ESC-2 was 1/Figure 3 Influence of ESCs on activities of caspase 3, 8, 9 in
NCI-H460 cells from implanted hollow fibers. The data were
expressed as mean ± SD (n = 6 per group). *p < 0.05, significant
versus control group.
Figure 4 Influence of ESCs on expression of Fas and Fas-L in
NCI-H460 cells from implanted hollow fibers. The data were
expressed as mean ± SD (n = 6 per group). ESCs treatment groups
has no significant change versus control group.
Figure 5 Influence of ESCs on expression of TNF-α and TNFR1
in NCI-H460 cells from implanted hollow fibers. The data were
expressed as mean ± SD (n = 6 per group). *p < 0.05, significant
versus control group.
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ous inhibitory effects on 4 cell tumor lines): ESC-2 >
ESC > ESC-1.
Comparison of sensitivity of ESCs to tumor cells, NCI-
H460 cell line was the most because that all ESCs had
inhibition on it. ESC-2 showed the strongest inhibition
and inhibition rates of two sites (SC and IP) of NCI-
H460 cells were more than 100%. Follow the ESC-2 was
ESC and inhibition rate of two sites (SC and IP) were
nearly 100%. Furthermore, ESC-1 showed certain inhib-
ition in SC site on NCI-H460 cells.
In our previous in vitro experiment, we found that
ESCs could induce the tumor cells apoptosis by activat-
ing death receptor pathway. Therefore we selected the
most sensitive NCI-H460 cell line to further confirm the
apoptotic effect of ESCs in vivo based on HFA. The flow
cytometry results showed that 4.5 mg/kg ESC, and
1.5 mg/kg ESC-2 increased significantly apoptosis rates
in NCI-H460 cells in vivo. Enzymatic activity assay also
confirmed the ESC and ESC-2 could significantly in-
crease the activities of caspase 3 and caspase 8 in NCI-
H460 cells. These results suggested that ESC and ESC-2
induce tumor cell apoptosis through activation signal ofthe death receptor pathway in vivo which was consistent
with the in vitro results [14,15].
The death receptor families contained Fas, TNFR1,
death receptor (DR3, DR5), TNF related apoptosis indu-
cing ligand receptor (TRAIL-R1, TRAIL-R2), etc. [17].
Which pathway would the ESCs acted on?
We tested the classic death receptors, Fas, TNFR1 and
their ligands Fas-L, TNF-α. The Fas/Fas-L system was a
key regulator of apoptosis. The results showed that ESC,
ESC-2 had no significant effects on Fas/Fas-L pathway
which was not consistent with the in vitro results.
Maybe after the metabolism in vivo, the targets of ESCs
changed. TNFR1/ TNF-α signal system was another im-
portant death receptor pathway which was not observed
in our in vitro experiment. TNF-α was a multifunctional
cytokine, mainly involving in inflammation and immune
responses. It had a direct cytotoxic effect on tumor cells
and could cause tumor necrosis. Recent researches had
demonstrated that TNF-α inhibited certain tumor cell
proliferation and induced apoptosis of tumor cells [18].
But few study focused on the role of endogenous tumor
TNF-α, some scholars believed that the endogenous
TNF-α could promote tumor cells to produce oxygen free
radical ions, causing DNA damage or fracture [19,20]
and was conducive to the treatment of tumors. Down-
regulation of endogenous TNF-α to increase sensitivity
of exogenous TNF-α (produced by other cells) on tumor
cells was believed to be another reason of TNF-α killing
Liu et al. BMC Complementary and Alternative Medicine 2014, 14:116 Page 7 of 8
http://www.biomedcentral.com/1472-6882/14/116tumor cells [21]. Other reports showed that TNF-α pro-
duced by tumor cells would injury normal tissue, promote
tumor metastasis and related to many paraneoplastic
syndrome (such as hypercalcemia, lipemia and tumor
associated cachexia) [22,23]. Visibly, endogenous TNF-α
is a double-edged sword. In this experiment, we observed
that regulation roles of ESC, ESC-2 on endogenous TNF-
α expression of tumor cells were opposite: 3.0 mg/kg ESC
significantly upregulated whereas 1.5, 1.0 mg/kg ESC-2
downregulated the expression of TNF-α. ESC might up-
regulate the level of TNF-α to direct its effect of killing
tumor and ESC-2 may downregulate endogenous TNF-α
to enhance sensitivity of exogenous TNF-α to tumor cells.
The possible and reasonable explanation for the results
was that because ESC-2 was isolated from ESC, the target
ingredients to TNF-α of ESC-2 may be changed.
TNFR1, another death receptor protein, combining
with TNF-α might induce typtical apoptosis of caspase
dependent pathway. On the other hand, this combin-
ation might activate the nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-κB) and c-Jun-N
terminal kinase (JNK) signal pathway by recruitment of
TNF receptor-associated factor (TRAF2) and Receptor
interacting protein (RIP) [24-26]. 1.0 mg/kg ESC-2 obvi-
ously increased TNFR1 expression which suggested that
ESC-2 inducing apoptosis of NCI-H460 cells might be
related to upregulation of TNFR1 receptor.
The results above showed ESC-2 had the similar antitu-
mor effect to that of ESC in vivo and further confirmed
that ESC-2 may be the main antitumor active fraction of
ESC, which was consistent with the in vitro result.Competing interests
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